Prognostic significance of elevated pre-treatment serum CA-125 levels in patients with stage I ovarian sex cord-stromal tumors
European Journal of Obstetrics & Gynecology and Reproductive Biology May 08, 2019
Nasioudis D, et al. - Researchers examined a total of 1156 patients diagnosed between 2004 and 2015 with a sex cord - stromal tumors (SCSTs) from the National Cancer Database for the prognostic significance of elevated pre-operative serum CA-125 values. Pre-treatment CA-125 values were elevated in 486 (42%). After controlling for patient age (<50 vs > = 50 yrs), the presence of medical co-morbidities, tumor histology (granulosa vs non-granulosa), size (<10 vs > = 10 cm vs unknown) and the performance of lymphadenectomy, elevated preoperative CA-125 levels were noted to be associated with worse survival in this large cohort of patients with early-stage SCSTs .
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries